Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Rigel Pharmaceuticals (RIGL)
Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 243,134
  • Shares Outstanding, K 173,667
  • Annual Sales, $ 120,240 K
  • Annual Income, $ -58,570 K
  • 60-Month Beta 0.72
  • Price/Sales 2.02
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RIGL with:

Options Overview Details

View History
  • Implied Volatility 158.40% ( +34.09%)
  • Historical Volatility 160.08%
  • IV Percentile 75%
  • IV Rank 22.27%
  • IV High 647.37% on 11/11/22
  • IV Low 18.31% on 09/21/22
  • Put/Call Vol Ratio 0.05
  • Today's Volume 44
  • Volume Avg (30-Day) 1,531
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 29,704
  • Open Int (30-Day) 24,284

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.08
  • Number of Estimates 4
  • High Estimate -0.08
  • Low Estimate -0.09
  • Prior Year -0.08
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1000 +27.27%
on 05/04/23
1.9600 -28.57%
on 05/18/23
+0.2600 (+22.81%)
since 05/02/23
3-Month
1.1000 +27.27%
on 05/04/23
1.9600 -28.57%
on 05/18/23
-0.2200 (-13.58%)
since 03/02/23
52-Week
0.6400 +118.75%
on 06/13/22
2.0400 -31.37%
on 01/23/23
-0.2600 (-15.66%)
since 06/02/22

Most Recent Stories

More News
Rigel Announces Poster Presentation at the Upcoming 2023 American Society of Clinical Oncology Annual Meeting

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced an upcoming poster presentation highlighting the Company's IRAK1/4 program at the...

RIGL : 1.4000 (unch)
Rigel to Present at the Jefferies 2023 Global Healthcare Conference

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will...

RIGL : 1.4000 (unch)
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Tops Revenue Estimates

Rigel (RIGL) delivered earnings and revenue surprises of 11.11% and 7.32%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RIGL : 1.4000 (unch)
AUPH : 9.54 (+4.61%)
Rigel: Q1 Earnings Snapshot

Rigel: Q1 Earnings Snapshot

RIGL : 1.4000 (unch)
Rigel Reports First Quarter 2023 Financial Results and Provides Business Update

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2023, including sales of...

RIGL : 1.4000 (unch)
Rigel Announces Conference Call and Webcast to Report First Quarter 2023 Financial Results and Business Update

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its first quarter 2023 financial results after market close on...

RIGL : 1.4000 (unch)
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc....

RIGL : 1.4000 (unch)
Stocks Little Changed Before The Open As Powell Comments Spark Fears of Higher Interest Rates

March S&P 500 futures (ESH23) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH23) are up +0.07% this morning after three major U.S. benchmark indices finished the regular session sharply lower as...

ESH23 : 3,957.05s (-0.09%)
NQM23 : 14,575.25s (+0.71%)
DKS : 128.41 (+1.73%)
RIVN : 14.48 (-0.69%)
SY1.D.DX : 101.150 (+0.05%)
FRTX : 0.5789 (+6.30%)
RIGL : 1.4000 (unch)
CRWD : 151.32 (-3.95%)
SFIX : 3.93 (+8.26%)
SHLS : 24.23 (-0.21%)
TSLA : 213.97 (+3.11%)
Rigel Pharmaceuticals (RIGL) Q4 Earnings and Revenues Surpass Estimates

Rigel (RIGL) delivered earnings and revenue surprises of 114.29% and 36.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

RIGL : 1.4000 (unch)
IMPL : 1.3200 (unch)
Rigel: Q4 Earnings Snapshot

Rigel: Q4 Earnings Snapshot

RIGL : 1.4000 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year....

See More

Key Turning Points

3rd Resistance Point 1.5200
2nd Resistance Point 1.4700
1st Resistance Point 1.4350
Last Price 1.4000
1st Support Level 1.3500
2nd Support Level 1.3000
3rd Support Level 1.2650

See More

52-Week High 2.0400
Fibonacci 61.8% 1.5052
Last Price 1.4000
Fibonacci 50% 1.3400
Fibonacci 38.2% 1.1748
52-Week Low 0.6400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar